Attitudes on Mind Over Matter: Physician Views on the Role of Placebo in Psychogenic Disorders

American Journal of Bioethics Neuroscience 4 (3):9-15 (2013)
  Copy   BIBTEX

Abstract

Psychogenic movement disorders (PMD) mimic known movement disorders, yet cannot be attributed to an underlying neurological substrate. PMD has been reported to affect up to 15–25% of patients who visit specialized movement disorder clinics. The lack of mechanistic understanding of this disorder contributes to the hesitation of physicians to give a diagnosis of PMD, and patients often experience inordinate health care costs and multiple referrals between psychiatrists and neurologists who have differing views on the diagnosis and terminology of PMD. Given that the prognosis for PMD is poor, that the success of standard treatment for PMD is highly dependent on the patient's belief in the diagnosis and treatment regimen, and that case studies suggest the efficacy of placebo for PMD, placebo therapy has recently been advocated for PMD. Recent surveys report a high percentage of physicians administering placebo therapy. Therefore, perhaps the ethical question in PMD should be, “Are we harming patients by withholding placebo treatment?” In order to determine whether placebo therapy would be a viable option for PMD, we must first rigorously assess the factors contributing to the medical contexts in which placebos are offered. We conducted in-depth interviews with neurologists and psychiatrists to assess the attitudes that contribute to ethical norms and to assess physician attitudes and practices surrounding placebo therapy to psychogenic patients. These data will serve to inform the future treatment of patients with PMD, to make recommendations for clinician training and healthcare policy, and to reframe and deepen our discussion of the value of placebo therapies.

Other Versions

No versions found

Links

PhilArchive

    This entry is not archived by us. If you are the author and have permission from the publisher, we recommend that you archive it. Many publishers automatically grant permission to authors to archive pre-prints. By uploading a copy of your work, you will enable us to better index it, making it easier to find.

    Upload a copy of this work     Papers currently archived: 102,323

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Physician perspectives on placebo ethics.John Bliamptis & Anne Barnhill - 2022 - Journal of Medical Ethics 48 (10):759-763.
Empirical evidence against placebo controls.Sadhvi Batra & Jeremy Howick - 2017 - Journal of Medical Ethics 43 (10):707-713.
Exploiting Placebo Effects for Therapeutic Benefit.Colin Cheyne - 2005 - Health Care Analysis 13 (3):177-188.
New theory of placebos reframes mind-body problem.Dien Ho - 2024 - Institute of Arts and Ideas.
The moral case for the clinical placebo.Azgad Gold & Pesach Lichtenberg - 2014 - Journal of Medical Ethics 40 (4):219-224.

Analytics

Added to PP
2018-06-22

Downloads
18 (#1,137,088)

6 months
2 (#1,608,553)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Provoking Pseudo-Seizures: Provocative Placebo Practices.Marleen Eijkholt & Timothy Lynch - 2013 - American Journal of Bioethics Neuroscience 4 (3):33-35.
Do Placebos Cause Their Effects and Does It Matter?Richard A. Kanaan - 2013 - American Journal of Bioethics Neuroscience 4 (3):35-36.

Add more citations